Skip to main content
Fig. 2 | Annals of Clinical Microbiology and Antimicrobials

Fig. 2

From: Trends in carbapenem resistance in Pre-COVID and COVID times in a tertiary care hospital in North India

Fig. 2

Frequency and distribution of various carbapenemases in the isolates. A Frequency of the common carbapenemases in the total number of resistant isolates during the two phases of the study. B Organism wise distribution of the common carbapenemases during the two phases of the study. EC: E. coli, KP: K. pneumoniae, AB: A. baumannii, PA: P. aeruginosa, Pre-COVID: August to October 2020; COVID: January to February 2021

Back to article page